会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 14.beta.-H-, 14-and 15-En-11.beta.-aryl-4-oestrenes
    • 14β-H,14和15-En-11β-芳基-4-盎司
    • US5426102A
    • 1995-06-20
    • US81269
    • 1993-06-22
    • Wolfgang SchwedeEckhard OttowGunter NeefArwed CleveKrzysztof ChwaliszHorst Michna
    • Wolfgang SchwedeEckhard OttowGunter NeefArwed CleveKrzysztof ChwaliszHorst Michna
    • A61K31/57A61K31/58A61K31/585A61P5/38C07J1/00C07J3/00C07J5/00C07J7/00C07J9/00C07J17/00C07J21/00C07J33/00C07J41/00C07J43/00
    • C07J1/0092C07J1/0088C07J1/0096C07J17/00C07J33/002C07J41/0094C07J43/003C07J9/00
    • Novel compounds of the general formula I ##STR1## and the pharmacologically tolerable addition salts thereof with acids are described, in which eitherIa) R.sup.11 represents a hydrogen atom in the .beta.-configuration and each of R.sup.12 and R.sup.13 represents a hydrogen atom, orIb) R.sup.11 represents a hydrogen atom in the .beta.-configuration and R.sup.12 and R.sup.13 together represent a second bond, orIc) R.sup.11 and R.sup.12 together represent a second bond and R.sup.13 represents a hydrogen atom, orId) R.sup.11 represents a hydrogen atom in the .alpha.-configuration and R.sup.12 and R.sup.13 together represent a second bond,and in Ia), Ib), Ic) or Id)X represents an oxygen atom, the hydroxyimino grouping >N.about.OH or two hydrogen atoms,R.sup.1 represents a hydrogen atom or a methyl group,R.sup.2 represents a hydroxy group, a C.sub.1 -C.sub.10 -alkoxy group or a C.sub.1 -C.sub.10 -acyloxy group, andR.sup.3 and R.sup.4 have the meanings customary for competitive progesterone antagonists specified in the description.The invention relates also to processes for the preparation of the novel compounds, to pharmaceutical compositions containing those compounds, to their use for the manufacture of medicaments, and to the novel intermediates required for the process.The novel compounds have a strong affinity for the gestagen receptor and exhibit pronounced antigestagenic and also antiglucocorticoid, antimineralocorticoid and antiandrogenic properties.
    • PCT No.PCT / EP91 / 02494 371日期:1993年6月22日 102(e)日期1993年11月1日PCT 1991年12月21日PCT PCT。 出版物WO92 / 11278 描述了通式I的新型化合物(Ⅰ)及其与酸的药理学上可以忍受的加成盐,其中Ia)R11表示β-构型中的氢原子, R 12和R 13表示氢原子,或Ib)R 11表示β构型中的氢原子,R 12和R 13一起表示第二键,或者Ic)R 11和R 12一起表示第二键,R 13表示氢原子,或 Id)R11表示α-构型中的氢原子,R 12和R 13一起表示第二键,并且在Ia),Ib),Ic)或Id)中X表示氧原子,羟基亚氨基> N不同OH或两个 氢原子,R 1表示氢原子或甲基,R 2表示羟基,C 1 -C 10 - 烷氧基或C 1 -C 10 - 酰氧基,R 3和R 4具有常规用于在 描述。 本发明还涉及制备新化合物的方法,含有这些化合物的药物组合物,其用于制备药物的方法以及该方法所需的新型中间体。 新化合物对于孕激素受体具有强烈的亲和力,并且具有显着的抗原成分和抗糖皮质激素,抗皮质激素和抗雄激素的特性。
    • 3. 发明授权
    • D-homo-(16-ene)-11.beta.-aryl-4-estrenes, process for their production
as well as their use as pharmaceutical agents
    • D-均聚(16-烯)-11β-芳基-4-雌酮,其制备方法以及作为药剂的用途
    • US5519027A
    • 1996-05-21
    • US78326
    • 1994-02-25
    • Wolfgang SchwedeEckhard OttowArwed CleveWalter ElgerKrzysztof ChwaliszMartin Schneider
    • Wolfgang SchwedeEckhard OttowArwed CleveWalter ElgerKrzysztof ChwaliszMartin Schneider
    • A61K31/57A61K31/58A61K31/585A61P5/38C07J1/00C07J3/00C07J5/00C07J7/00C07J21/00C07J41/00C07J63/00A61K31/565
    • C07J63/008
    • New D-homo-(16-ene)-11.beta.-aryl-4-estrenes of general formula I ##STR1## as well as their pharmaceutically compatible addition salts with acids are described in whichX stands for an oxygen atom, the hydroxyimino grouping >N.about.OH or two hydrogen atoms,R.sup.1 stands for a hydrogen atom or a methyl group,R.sup.2 stands for an hydroxy group, a C.sub.1 -C.sub.10 alkoxy or C.sub.1 -C.sub.10 acyloxy group,R.sup.11 stands for a fluorine, chlorine or bromine atom, and then R.sup.12 and R.sup.13 together mean an additional bond orR.sup.11 stands for a straight-chain or branched-chain C.sub.1 -C.sub.4 -alkyl radical or a hydrogen atom, and then R.sup.12 and R.sup.13 each mean a hydrogen atom or together mean an additional bond,and R.sup.3 and R.sup.4 have the usual meanings indicated in the description for competitive progesterone antagonists.The invention further relates to a process for the production of new compounds, pharmaceutical preparations containing these compounds, their use for the production of pharmaceutical agents as well as the new intermediate products necessary for the process.The new compounds have a strong affinity to the gestagen receptor and show strong antigestagen as well as antiglucocorticoid, antimineral corticoid and antiandrogenic properties.
    • PCT No.PCT / EP91 / 02495 371日期1994年2月25日 102(e)1994年2月25日PCT PCT 1991年12月21日PCT公布。 出版物WO92 / 11279 日期:1992年7月9日。通式I(I)的新型D-均 - (16-烯)-11β-芳基-4-雌酮及其与酸的药学上相容的加成盐描述于其中 X表示氧原子,羟基亚氨基> N不同OH或两个氢原子,R1表示氢原子或甲基,R2表示羟基,C1-C10烷氧基或C1-C10酰氧基,R11 代表氟,氯或溴原子,然后R 12和R 13一起表示另外的键或R 11表示直链或支链的C 1 -C 4烷基或氢原子,则R 12和R 13各自表示 氢原子或一起表示另外的键,并且R3和R4具有在竞争性孕酮拮抗剂的描述中指出的通常含义。 本发明还涉及生产新化合物的方法,含有这些化合物的药物制剂,其用于生产药物的用途以及该方法所需的新的中间产物。 新化合物对孕激素受体具有强烈的亲和力,并显示出强的抗老化,以及抗糖皮质激素,抗癫痫皮质激素和抗雄激素的特性。